Pediatric Clinical Trials

California Pacific CURRENTS: The online journal of CPMC Research Institute

Below is a listing of clinical trials for pediatrics approved by CPMC's Institutional Review Board:


Compassionate Use of Omegaven IV Fat Emulsion in Infants With Life Threatening Parenteral Nutrition-associated Liver Disease (PNALD)

Description: The purpose of the study is to provide use of Omegaven in infants with life threatening Total Parenteral Nutrition (TPN) associated cholestasis when all other medical and surgical treatments/therapies have been either ineffective or not feasible in the treatment of this serious condition. This is a compassionate use protocol.


  • David A. Lee, MD

Eligibility Requirements

Infants, 2 months to 12 months old, with a diagnosis of life threatening PNALD and who are currently admitted to the NICU


Active and open to enrollment


David A. Lee, MD, 415-750-6842